Mesalamine
An anti-inflammatory drug used to treat and maintain remission of ulcerative colitis and other inflammatory bowel conditions affecting the lining of the colon. It works locally in the gut to reduce inflammation and relieve symptoms such as diarrhea, rectal bleeding, and abdominal pain.
Peso molecular
153,1400 g/mol
LogP
1,30
TPSA
83,60 Ų
Regla de cinco de Lipinski
Cumple
Áreas terapéuticas
Mecanismo de acción
Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.
Estructura 2D
Cite this structure
Embed this structure
SMILES
Nc1ccc(O)c(C(=O)O)c1
InChI
InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)
Molecular Formula
C7H7NO3
HBD / HBA
3 / 4
Enlaces Rotables
1
Átomos Pesados
11
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
An anti-inflammatory drug used to treat and maintain remission of ulcerative colitis and other inflammatory bowel conditions affecting the lining of the colon. It works locally in the gut to reduce inflammation and relieve symptoms such as diarrhea, rectal bleeding, and abdominal pain.
Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.
Yes, Mesalamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL704. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 4075. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="mesalamine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/mesalamine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/mesalamine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/mesalamine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="mesalamine"></drugfyi-drug>